The Development and Evaluation of an "E-Visit" Program for the Management of Acne
The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:
- That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.
- That providers and patients will be satisfied with this model.
- That mean wait times for new and return visits will be reduced through the "E-Visit" model.
- That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||The Development and Evaluation of an "E-Visit" Program for the Management of Acne|
- Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment [ Time Frame: 6 months ]
- Subject satisfaction [ Time Frame: 6 months ]
- Physician satisfaction [ Time Frame: 6 months ]
- Timing of visits [ Time Frame: ongoing ]
|Study Start Date:||October 2005|
|Study Completion Date:||December 2007|
|Primary Completion Date:||December 2007 (Final data collection date for primary outcome measure)|
Active Comparator: 1
Other: Office visit
Conventional office-based care
Asynchronous,remote care delivery via a secure web platform
Other Name: RelayHealth platform
Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.
Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.
Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:
Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.
Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.
At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00417456
|United States, Massachusetts|
|MGH Dermatology Associates|
|Boston, Massachusetts, United States, 02114|
|Brigham and Women's Hospital Department of Dermatology|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Joseph C. Kvedar, M.D.||Massachusetts General Hospital|